Document Treatment-Relapse Evidence and Limits

To document treatment relapse evidence and limits, report Jules's decision, response classes, phase and context histories, treatment versions, reinforcement, exposure, integrity, access, health, recurrence timing, raw counts, safety actions, direct experience, candidate process, alternatives, design limits, qualified interpretation, repairs, decisions, and triggers. Keep the claim tied to the supported sequence rather than describing relapse as a personal trait or inevitable outcome.

Lead with Jules's decision and authority

State the practical question, Jules's priority, qualified interpreter, contributors, dates, settings, consent route, assent when applicable, and immediate safety or repair actions.

Show the complete history

Present response definitions, phase and context versions, treatment, reinforcement, exposure, integrity, access, health, recurrence, repair, and follow-up in chronological order.

Report units and denominators explicitly

Separate events, opportunities, sessions, durations, people, and cases. Show planned, valid, invalid, missing, and withdrawn units with raw counts beside percentages.

State process and causal limits

Explain whether resurgence, renewal, integrity failure, access change, health change, ordinary variation, or another account is supported, merely possible, contradicted, or unavailable.

Use this sequence to document treatment relapse evidence and limits

Lead with Jules's decision, preserve history and units, report repairs and experience, bound process claims, name alternatives, record corrections, and set a specific reassessment trigger.

Build Jules's treatment-relapse evidence report

Create one versioned treatment-relapse evidence report for the community art-studio closing routine. Include Jules's priority, response classes, phases, contexts, treatment versions, reinforcement, exposure, integrity, access, health, recurrence timing, safety action, direct experience, invalidity, missingness, withdrawal, candidate process, alternative explanations, design limits, decision, qualified owner, correction, and reassessment trigger. Store only decision-relevant information with role-limited access.

Validate Jules's recurrence evidence

Reproduce Jules's 8 + 12 + 8 + 6 = 34 valid opportunities plus two invalid = 36 planned, with 6/8 baseline, 1/12 treatment, 7/8 context-change, and 1/6 repair results. Verify response and event units, phases, contexts, treatment versions, reinforcement, exposure, integrity, access, health, experience, safety, alternatives, corrections, and decision ownership.

Connect Jules's evidence to a decision

Jules's conclusion table pairs each statement with its evidence class and action. Descriptive recurrence can support repair, stronger phase evidence may support a bounded clinical change, and missing history can support prospective monitoring or closure. The report names the qualified owner for every decision.

Work through Jules's example

Jules has 36 planned closing opportunities across baseline, treatment, context change, and repair. Two are invalid after supply-room closure. The prior target response occurs in 9/8 baseline opportunities only if multiple events are counted, revealing the wrong unit; by opportunity it occurs in 6/8. It later occurs in 1/12 treatment, 7/8 context-change, and 1/6 repair opportunities. The report uses opportunity-level results. Preserve every planned and valid unit, response code, phase and context version, treatment component, reinforcement event, exposure, integrity result, access and health state, safety response, withdrawal, direct report, system failure, repair, correction, and unresolved item. This fictional example demonstrates one assessment control. It offers no diagnosis, person trait, universal relapse estimate, treatment effect, legal conclusion, coverage decision, payment promise, or outcome guarantee for Jules.

Address Jules's main interpretation risk

A numerator larger than its opportunity denominator can be valid for event rate and invalid for opportunity percentage. Mixing those units hides the error. Calling 7/8 renewal without context integrity, treatment continuity, and support access would also exceed the record. Review response and phase definitions, treatment history, reinforcement, exposure, context, integrity, access, health, partner behavior, direct experience, alternative explanations, authority, and design strength separately. A convincing graph cannot repair an unsafe, inaccessible, unwanted, or historically unsupported recurrence assessment.

Keep treatment scope and authority clear for Jules

For Jules's treatment-relapse evidence report, the CASP public summary supplies high-level ABA behavioral-health-treatment scope for autistic people, with licensed detail outside this page. The current BACB Ethics Code addresses competence, client involvement, consent and assent when applicable, medical needs, risk, data, documentation, evaluation, discontinuation, and transition for covered people. The BACB outline supplies examination content. These sources create no individualized relapse protocol or practice authority for Jules.

Distinguish early increase from recurrence for Jules

The historical Lerman and Iwata analysis reviewed extinction data and found early increases under a defined burst criterion in a minority of reviewed data sets. An extinction burst describes a time-linked early increase after extinction begins, whereas Jules's later recurrence question requires its own phase history. The study offers no universal prevalence estimate for current care, no safety authorization, and no prediction for the community art-studio closing routine.

Use alternative-reinforcement and communication literature within scope for Jules

Athens and Vollmer evaluated differential reinforcement without extinction with seven children and varied dimensions such as immediacy, duration, and quality. The Tiger, Hanley, and Bruzek review discusses FCT assessment, response selection, partner response, schedule thinning, and related risks. These sources support careful history and delivery measurement for Jules; they supply no universal schedule, delay, consequence, or relapse outcome.

Use renewal evidence cautiously for Jules

The Podlesnik renewal review synthesizes basic and translational work on recurrence with context change while extinction or treatment contingencies remain. Much of that evidence comes from controlled laboratory arrangements. Understanding and Reacting to Relapse discusses practice-facing context and recurrence considerations. For Jules, define people, places, cues, treatment continuity, access, and integrity before applying renewal language.

Preserve broad relapse limits and communication access for Jules

Relapse and Its Mitigation distinguishes several recurrence histories and discusses mitigation concepts. It organizes hypotheses rather than proving which process occurred for Jules. ASHA's AAC portal says AAC users should always have access to communication tools or devices. Follow governing sources and preserve Jules's communication, health care, food, water, bathroom use, mobility, rest, relationships, safety, and emergency help throughout review.

Choose Jules's next bounded action

Jules corrects the unit label, adds the supply-room invalid events, and asks the studio to preserve the same closing checklist in the second room. Record the qualified owner, source evidence, effective date, current phase and treatment version, ordinary supports, access and health state, implementation check, accessible explanation, disagreement route, and reassessment trigger. Preserve the earlier record when responses, people, settings, systems, schedules, health, or priorities change. A repaired arrangement creates a dated phase rather than an error in Jules's prior performance.

Close Jules's relapse review

Review the treatment-relapse evidence report with Jules, the qualified behavior analyst, relevant partners, access owners, and specialists named in the manifest. Confirm that observed recurrence remains separate from resurgence, renewal, an extinction burst, treatment drift, access failure, health change, and treatment effect; every denominator is reproducible; AAC and basic access remain protected; urgent needs received action; and conclusions stay bounded to the supported history. Keep this page draft and noindex until every required review is complete.

How to Document Treatment-Relapse Evidence and Limits